未登录

M

Matthew S. Ellis

psychiatry

H指数:29

被引数:4,482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HIV Pre-Exposure Prophylaxis Awareness among Individuals in Treatment for Opioid Use Disorder in the United States: A Cross-Sectional Study

美国接受阿片类药物滥用治疗人群中HIV暴露前预防的认知情况：一项横断面研究

AIDS and Behavior

IF2.4

2026-03-170

OAAI

Use of Gabapentin With or Without a Prescription in Substance Use Treatment Settings: A National Analysis of Urine Drug Testing Data, 2016-2023

在物质使用治疗环境中使用加巴喷丁（无论是否凭处方）的情况：基于2016-2023年尿液药物检测数据的全国性分析

Drug and Alcohol Dependence

IF3.6

2026-01-030

PRE

People entering opioid substance use treatment have low rates of naloxone knowledge and possession

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-03-010

PRE

GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Understanding Ketamine Use in Treatment-Seeking Persons With Opioid Use Disorder

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder

HARM REDUCTION JOURNAL

IF4

2024-01-192

OAAI

Associations of Transactional Sex and Sexually Transmitted Infections Among Treatment-Seeking Individuals With Opioid Use Disorder

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2023-01-013

PRE

Understanding motivations and use typologies of gabapentin with opioid agonist medications

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2023-01-011

PRE

Editorial: Broadening the scope of addiction medicine: Integrating co-morbid conditions, polysubstance use, and patient experiences into substance use treatment

FRONTIERS IN PSYCHIATRY

IF3.2

2022-11-070

OAAI

Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations

治疗性和非治疗性阿片类药物人群对阿片类药物过量风险的自我识别和纳洛酮认知的差异

JOURNAL OF ADDICTION MEDICINE

IF3.2

2022-09-222

PRE

Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-05-018

PRE

Shifting Pathways of Stimulant Use Among Individuals With Opioid Use Disorder: A Retrospective Analysis of the Last Thirty Years

FRONTIERS IN PSYCHIATRY

IF3.2

2021-12-205

OAAI

Opioid Dosage Levels, Concurrent Risk Factors and Self-Perceptions among Chronic Pain, Opioid-Managed Individuals at Elevated Risk for Opioid Overdose

PHARMACEUTICALS

IF4.8

2021-12-082

OAAI

Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings

农村和城市地区阿片类药物使用障碍患者的多物质使用趋势和变异性

PREVENTIVE MEDICINE

IF3.2

2021-11-0125

PREAI

Assessment of Chronic Pain Management in the Treatment of Opioid Use Disorder: Gaps in Care and Implications for Treatment Outcomes

阿片类药物使用障碍治疗中慢性疼痛管理的评估：护理缺口及其对治疗结局的影响

JOURNAL OF PAIN

IF4

2021-04-0130

OAAI

Destigmatizing Naloxone: Associations of Perceived Availability on Opioid Use Patterns

ANNALS OF EMERGENCY MEDICINE

IF5

2021-01-016

OAAI

Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis

AMERICAN JOURNAL OF PUBLIC HEALTH

IF9.6

2020-02-01212

OAAI

The impact of opioid use disorder on levels of educational attainment: Perceived benefits and consequences

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2020-01-0116

PREAI

Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers

JOURNAL OF SUBSTANCE ABUSE TREATMENT

IF4

2019-10-0113

OAAI

Increased use of heroin as an initiating opioid of abuse: Further considerations and policy implications

ADDICTIVE BEHAVIORS

IF3.6

2018-12-0146

PREAI